MAGI3 and nonpapillary renal cell carcinoma: Given that the inhibition of the ERK signaling pathway is a major mechanism through which Sunitinib suppresses tumor cell proliferation, we examined the impact of MAGI3 expression on Sunitinib sensitivity in ccRCC cells.